A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy

Part of paid clinical trials in Glendale, California.

Sponsor
Eli Lilly and Company
Study ID
NCT02973100
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Dulaglutide — DRUG
    Administered SC
  • Placebo — DRUG
    Administered SC

Study Details

The purpose of this study is to evaluate the efficacy and safety of investigational doses of dulaglutide in participants with type 2 diabetes on metformin monotherapy.

Key Dates

Start date
Dec 31, 2016
Status verified
Sep 2019
Primary completion
Jul 15, 2017
Completion
Aug 14, 2017

Study Design

Enrollment
318 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Dulaglutide 4.5mg
    4.5mg of Dulaglutide administered subcutaneously (SC)
  • Experimental: Dulaglutide 3.0mg
    3.0mg of Dulaglutide administered SC
  • Active Comparator: Dulaglutide 1.5mg
    1.5mg of Dulaglutide administered SC
  • Placebo Comparator: Placebo
    Placebo administered SC

Primary Outcome Measure

Change From Baseline in Hemoglobin A1c (HbA1c) [ Time Frame: Baseline, Week 18 ]

Locations (38)

FacilityCityStateZIPSite coordinators
Parexel Early Phase Unit at GlendaleGlendaleCalifornia91206-4140-
Marin Endocrine AssociatesGreenbraeCalifornia94904-
National Research InstituteHuntington ParkCalifornia90255-
National Research InstituteLos AngelesCalifornia90057-
Catalina Research Institute, LLCMontclairCalifornia91763-
Artemis Institute for Clinical ResearchSan DiegoCalifornia92103-
Encompass Clinical ResearchSpring Valley LakeCalifornia91978-
University Clinical Investigators, Inc.TustinCalifornia92780-
InfosphereVan NuysCalifornia91405-
Diablo Clinical ResearchWalnut CreekCalifornia94598-
Chase Medical Research, LLCWaterburyConnecticut06708-
Axes Medical Research, LLCCooper CityFlorida33024-
Clinical Research of South FloridaCoral GablesFlorida33134-
East Coast Institute For ResearchJacksonvilleFlorida32204-
New Horizon Research CenterMiamiFlorida33175-
Suncoast Research Group, LLCMiami LakesFlorida33135-
Palm Harbor Medical AssociatesPalm HarborFlorida34684-
In-Quest Medical Research, LLC - NorcrossNorcrossGeorgia30071-
East West Medical InstituteHonoluluHawaii96814-
Elite Cilnical Trials LLLPBlackfootIdaho83221-
Solaris Clinical ResearchMeridianIdaho83646-
HSHS Medical Group Diabetes ResearchSpringfieldIllinois62711-
American Health NetworkIndianapolisIndiana46254-
Iderc, P.L.C.Des MoinesIowa50314-
Cotton O'Neil Diabetes and Endocrinology CenterTopekaKansas66606-
ActivMed Practices & Research, IncMethuenMassachusetts01844-
StudyMetrix Research, LLCCity of Saint PetersMissouri63303-
Manhattan Medical ResearchNew York MillsNew York10016-
High Point Clinical Trials CenterHigh PointNorth Carolina27265-
Aventiv ResearchColumbusOhio43213-
The Corvallis Clinic P.C.CorvallisOregon97330-
Heritage Valley Medical Group, Inc.BeaverPennsylvania15009-
New Phase Research & DevelopmentKnoxvilleTennessee37909-
Dallas Diabetes Endocrine CenterDallasTexas75230-
Consano Clinical ResearchSan AntonioTexas78231-
Clinpoint Trial, LLCWaxahachieTexas75165-
Chrysalis Clinical ResearchSt. GeorgeUtah84790-
Rainier Clinical Research CenterRentonWashington98057-

Find similar trials in Glendale, CA

By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Parexel Early Phase Unit at Glendale· Glendale, CAMarin Endocrine Associates· Greenbrae, CANational Research Institute· Huntington Park, CANational Research Institute· Los Angeles, CACatalina Research Institute, LLC· Montclair, CAArtemis Institute for Clinical Research· San Diego, CA

Related Studies